S'abonner

Higher Gestational Choline Levels in Maternal Infection Are Protective for Infant Brain Development - 24/04/19

Doi : 10.1016/j.jpeds.2018.12.010 
Robert Freedman, MD 1, , Sharon K. Hunter, PhD 1, Amanda J. Law, PhD 1, 2, Brandie D. Wagner, PhD 6, Angelo D'Alessandro, PhD 3, Uwe Christians, MD, PhD 4, Kathleen Noonan, MSW 1, Anna Wyrwa, MS 1, M. Camille Hoffman, MD 1, 5
1 Department of Psychiatry, University of Colorado Denver School of Medicine, Aurora, CO 
2 Department of Cell and Developmental Biology, University of Colorado Denver School of Medicine, Aurora, CO 
3 Department of Biochemistry and Molecular Genetics, University of Colorado Denver School of Medicine, Aurora, CO 
4 Department of Anesthesiology, University of Colorado Denver School of Medicine, Aurora, CO 
5 Department of Obstetrics and Gynecology, University of Colorado Denver School of Medicine, Aurora, CO 
6 Department of Biostatistics and Informatics, Colorado School of Public Health (BDW), Aurora, CO 

Reprint requests: Robert Freedman, Department of Psychiatry F546, University of Colorado Denver School of Medicine, 13001 E 17th Place, Aurora, CO 80045.Department of Psychiatry F546University of Colorado Denver School of Medicine13001 E 17th PlaceAuroraCO80045

Abstract

Objective

To assess whether maternal choline decreases effects of mothers' infections on fetal brain circuit development and on expression of infant behavior at 1 year of age.

Study design

A cross-sectional study was conducted in a public hospital obstetrics and midwifery service, with prenatal assessments of maternal infection, C-reactive protein, and choline level and postnatal assessments of cerebral neuronal inhibition in 162 newborns. At 1 year, 136 parents completed reports of their child's behavior.

Results

Maternal infection at 16 weeks of gestation, experienced by 41% of mothers, raised mean maternal C-reactive protein (d’ = 0.47, P = .002) and decreased the development of cerebral inhibition of auditory response at 1 month of age (d’ = 0.39, P < .001). Decreased newborn cerebral inhibition manifested as decreased behavioral self-regulation at 1 year. Greater choline levels in mothers with infections were associated with improved newborn inhibition of auditory cerebral response, mitigating the effect of infection (β = −0.34 [95% CI, −5.35 to −0.14], P = .002). At 1 year of age, children of mothers with infection and greater gestational choline levels had improved development of self-regulation, approaching the level of children of mothers without infection (β = 0.29 [95% CI 0.05-0.54], P = .03).

Conclusions

Greater maternal choline, recommended by the American Medical Association as a prenatal supplement, is associated with greater self-regulation among infants who experienced common maternal infections during gestation. Behavioral problems with diminished self-regulation often lead to referrals to pediatricians and might lead to later mental illness.

Le texte complet de cet article est disponible en PDF.

Keywords : pregnancy exposure delayed effects, fetal development, choline, receptors nicotinic, sensory gating, child behavior

Abbreviations : ADHD, CRP, IBQ-R, P50, REM


Plan


 Supported by the National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development (K12HD001271-11 [to M.H.] and National Center for Advancing Translational Sciences (UL1 TR001082 [to all investigators]), and by the Institute for Children’s Mental Disorders and the Anschutz Foundation (to R.F.). The funders had no role in (1) study design; (2) the collection, analysis, and interpretation of data; (3) the writing of the report; and (4) the decision to submit the paper for publication. The authors declare no conflicts of interest.


© 2019  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 208

P. 198 - mai 2019 Retour au numéro
Article précédent Article précédent
  • Assessment of Brain Injury and Brain Volumes after Posthemorrhagic Ventricular Dilatation: A Nested Substudy of the Randomized Controlled ELVIS Trial
  • Mehmet N. Cizmeci, Nadieh Khalili, Nathalie H.P. Claessens, Floris Groenendaal, Kian D. Liem, Axel Heep, Isabel Benavente-Fernández, Henrica L.M. van Straaten, Gerda van Wezel-Meijler, Sylke J. Steggerda, Jeroen Dudink, Ivana Išgum, Andrew Whitelaw, Manon J.N.L. Benders, Linda S. de Vries, ELVIS study group, K. Han, P. Woerdeman, H.J. ter Horst, K.P. Dijkman, D. Ley, V. Fellman, T.R. de Haan, A.J. Brouwer, E. van ‘t Verlaat, P. Govaert, B.J. Smit, T. Agut Quijano, U. Barcik, A. Mathur, A.M. Graca
| Article suivant Article suivant
  • Cerebral Oxygen Saturation and Negative Postoperative Behavioral Changes in Pediatric Surgery: A Prospective Observational Study
  • Estefanía Gómez-Pesquera, Rodrigo Poves-Alvarez, Beatriz Martinez-Rafael, Pilar Liu, Javier Alvarez, Mario Lorenzo-López, Inmaculada Fierro, Esther Gómez-Sánchez, María Heredia-Rodriguez, José Ignacio Gómez-Herreras, Eduardo Tamayo

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2025 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.